PHAXIAM Provides An Update On The Deployment Of Its Strategy To Maximize The Development Potential Of Phage Therapy
PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company ("PHAXIAM" or "the Company") developing innovative treatments for severe and resistant bacterial infections, announced ...
Transfer news LIVE: Mathys Tel bid accepted, Arsenal block move, Salah silence broken, Duran medical
There's less than a week remaining of the January transfer window and Premier League clubs could be in line for a busy few ...